Develop, Sell and Partner Opexa Therapeutics (NASDAQ: OPXA)
December 2nd, 2009
No comments
Opexa Therapeutics, Inc. is develops of patient-specific cellular therapies for the treatment of autoimmune diseases. Market Opportunity: The name Multiple Sclerosis (MS) simply refers to the buildup of scar tissue in the brain and spinal cord. An unpredictable disease of the central nervous system, multiple sclerosis can range from being relatively benign to somewhat disabling to devastating as communication between the brain and other parts of the body is disrupted. Read more…
Categories: Independent Equity Research, Stem Cell Technology
